Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

Mechanism of Action of Auranofin on Burkholderia cenocepacia

EF 2019-20

Résumé
"Antibiotic resistance is an increasing problem for treating individuals infected with bacteria. For example in Cystic Fibrosis, patients infected with Burkholderia cenocepacia are often excluded from lung transplantations, therefore, finding a way to clear this infection can bring hope to more individuals suffering with Cystic Fibrosis. A medication currently in use, auranofin, has been shown to have antibiotic activity towards other species of bacteria. Auranofin is used to treat inflammation in individuals with rheumatoid arthritis. We have found that auranofin derivatives have antibiotic activity against Burkholderia cenocepacia. I will be using this drug and derivatives of it to find the mechanism of action or how the drug affects/kills the bacteria. "
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
429017
Name
Maydaniuk Dustin
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Mechanism of Action of Auranofin on Burkholderia cenocepacia
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotic Resistance; Antibiotics; Antimicrobial; Auranofin; Burkholderia Cenocepacia; Cystic Fibrosis; Microbiology
Abstract
"Antibiotic resistance is an increasing problem for treating individuals infected with bacteria. For example in Cystic Fibrosis, patients infected with <em>Burkholderia</em> <em>cenocepacia</em> are often excluded from lung transplantations, therefore, finding a way to clear this infection can bring hope to more individuals suffering with Cystic Fibrosis. A medication currently in use, auranofin, has been shown to have antibiotic activity towards other species of bacteria. Auranofin is used to treat inflammation in individuals with rheumatoid arthritis. We have found that auranofin derivatives have antibiotic activity against <em>Burkholderia</em> <em>cenocepacia</em>. I will be using this drug and derivatives of it to find the mechanism of action or how the drug affects/kills the bacteria. <em></em>"
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Maydaniuk, Dustin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~